Company news
Henan Lingrui Pharmaceutial Co., Ltd. news in 2026
Henan Lingrui Pharmaceutial Co., Ltd.'s news releases, calls and decks from 2026, newest first.
(600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Report for Q3 2026
October 29, 2026
(600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Convening the Q3 2026 Performance Briefing
October 29, 2026
(600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge of Certain Shares Held by Major Shareholder
October 13, 2026
(600285)"HENAN LINGRUI PHARMACEUTICAL CO., LTD."Announcement on Release of Pledge and Re-pledge of Certain Shares Held by Major Shareholder
September 29, 2026
Announcement on Pledge of Certain Shares Held by Major Shareholder
August 21, 2026
Semi-annual Report for 2026
August 11, 2026
Announcement on Release of Pledge and Re-pledge of Certain Shares Held by Major Shareholder
August 4, 2026
Announcement on Inclusion of Products of the Company and Its Subsidiaries in the "National Essential Medicines List (2026 Edition)"
July 10, 2026
Announcement on Obtaining Notice of Approval for Drug Supplementary Application
June 23, 2026
Announcement on Resolutions of the 2nd Meeting of the 10th Board of Directors
June 11, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 4, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
May 21, 2026
Announcement on Election of Employee Representative Directors for the 10th Board of Directors
May 20, 2026
Announcement on the Release of Pledge of Partial Shares by Major Shareholders
April 29, 2026
Announcement on Obtaining Drug Registration Certificate
April 28, 2026
Announcement on Renewing Engagement of Accounting Firm
April 27, 2026
Announcement on the Pledge of Partial Shares by the Majority Shareholders
March 24, 2026
Announcement on Results of Shareholding Reduction by Director
January 14, 2026
Announcement on "Corporate Value and Return Enhancement" Action Plan
December 31, 2025